Patient-derived induced pluripotent stem cell organoids for amyotrophic lateral sclerosis drug discovery
Complex biological mechanisms and unidentified therapeutic targets for amyotrophic lateral sclerosis (ALS) significantly hinder the development of effective treatments. Given these challenges, reliable disease models that accurately replicate ALS phenotypes with relevant biological underpinnings are...
Saved in:
| Main Authors: | Wenyan Li, Jingqi Liu, Wenting Li, Lina Sun, Hao Zhang, Lei Gao, Chong Gao |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Compuscript Ltd
2025-01-01
|
| Series: | Acta Materia Medica |
| Online Access: | https://www.scienceopen.com/hosted-document?doi=10.15212/AMM-2024-0077 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Amyotrophic lateral sclerosis: an emerging era of collaborative gene discovery.
by: Katrina Gwinn, et al.
Published: (2007-12-01) -
Stem Cell Therapy for the Treatment of Amyotrophic Lateral Sclerosis: Comparison of the Efficacy of Mesenchymal Stem Cells, Neural Stem Cells, and Induced Pluripotent Stem Cells
by: Lauren Frawley, et al.
Published: (2024-12-01) -
Protocol for the induction of human spinal motor neurons from human induced pluripotent stem cells for studying amyotrophic lateral sclerosis
by: Selena Setsu, et al.
Published: (2025-09-01) -
Eosinophil-Derived Neurotoxin Is Elevated in Patients with Amyotrophic Lateral Sclerosis
by: Guan-Ting Liu, et al.
Published: (2013-01-01) -
Design Principles for Pluripotent Stem Cell-Derived Organoid Engineering
by: Teresa P. Silva, et al.
Published: (2019-01-01)